Plasmonix

BiotechnologySeries ABaltimore, USplasmonixinc.com

Latest round

Series A

Last raised

Nov 2013

Total raised

$0.2M

Investors

1

About Plasmonix

Founded in 2009, Plasmonix operates out of Baltimore, US, focusing on innovative software development.310 mn. The company has shown consistent strategies in its business operations but has not publicly disclosed any significant pivots or changes. There are no mentions of parent or subsidiary structures.Plasmonix specializes in innovative software development methodologies, primarily focusing on Scrum development frameworks that enable agile project management. Their core offerings revolve around creating efficient workflows through small, cross-functional teams that iteratively enhance product features over short cycles. This approach allows for rapid feedback and adjustments, effectively addressing client needs in real-time. The primary target clientele includes technology firms and organizations seeking to transition from traditional waterfall project management to more dynamic and responsive project handling.The company generates revenue through direct partnerships with businesses that adopt its Scrum development frameworks. The transaction structure typically involves B2B engagements, where firms pay for tailored consulting and implementation services associated with Scrum methodologies. Pricing plans are strategically designed based on project scope and client requirements, encompassing a range of services from initial consultation to comprehensive project management training. The company’s flagship service includes comprehensive Scrum training workshops, which equip teams with the skills needed to effectively utilize this agile approach in their workflows. The company is currently focusing on the development of new products surrounding enhanced Scrum methodologies aimed at improving agile project management. Furthermore, Plasmonix plans to expand its market reach into North America and Europe by 2016, enhancing its footprint in regions where Scrum practices are increasingly adopted.

Who invested in Plasmonix

1 investor across 1 round

See all investors in Plasmonix

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 13, 2013

    Amount

    $0.2M

    Investors

    Locked

Questions about Plasmonix

Who invested in Plasmonix?

Plasmonix has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Plasmonix raised?

Plasmonix has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Plasmonix last raise money?

Plasmonix's most recent round on record is a Series A, in Nov 2013.

What does Plasmonix do?

Founded in 2009, Plasmonix operates out of Baltimore, US, focusing on innovative software development.

Where is Plasmonix headquartered?

Plasmonix is headquartered in Baltimore, US.

Which VCs invest in companies like Plasmonix?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Plasmonix's stage. Their profiles are linked below.

Raising like Plasmonix? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.